Lixte Biotechnology Holdings Files 8-K
Ticker: LIXT · Form: 8-K · Filed: Mar 28, 2024 · CIK: 1335105
| Field | Detail |
|---|---|
| Company | Lixte Biotechnology Holdings, INC. (LIXT) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing, stock
Related Tickers: LIXT
TL;DR
LIXT filed an 8-K on March 27th regarding stock and warrants.
AI Summary
Lixte Biotechnology Holdings, Inc. filed an 8-K on March 28, 2024, reporting an event on March 27, 2024. The filing indicates changes related to common stock and warrants to purchase common stock. The company is incorporated in Delaware and its principal executive offices are located in Pasadena, California.
Why It Matters
This filing signals potential changes in the company's capital structure, which could impact share count and outstanding warrants.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate events and does not immediately indicate significant financial distress or major strategic shifts.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer
- March 27, 2024 (date) — Date of earliest event reported
- March 28, 2024 (date) — Date of report
- 001-39717 (company) — Commission File Number
- 20-2903526 (company) — IRS Employer Identification No.
FAQ
What specific event occurred on March 27, 2024, that necessitated this 8-K filing?
The filing indicates an event occurred on March 27, 2024, related to common stock and warrants, but the specific details of the event are not elaborated in the provided text.
What is the Commission File Number for Lixte Biotechnology Holdings, Inc.?
The Commission File Number for Lixte Biotechnology Holdings, Inc. is 001-39717.
Where are Lixte Biotechnology Holdings, Inc.'s principal executive offices located?
The principal executive offices of Lixte Biotechnology Holdings, Inc. are located at 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101.
What is the IRS Employer Identification Number for Lixte Biotechnology Holdings, Inc.?
The IRS Employer Identification Number for Lixte Biotechnology Holdings, Inc. is 20-2903526.
What is the state of incorporation for Lixte Biotechnology Holdings, Inc.?
Lixte Biotechnology Holdings, Inc. is incorporated in Delaware.
Filing Stats: 372 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2024-03-27 19:51:37
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-011582.txt ( ) — 267KB
- lixt-20240327.xsd (EX-101.SCH) — 3KB
- lixt-20240327_def.xml (EX-101.DEF) — 26KB
- lixt-20240327_lab.xml (EX-101.LAB) — 36KB
- lixt-20240327_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 27, 2024 LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Registrant) By: /s/ BASTIAAN VAN DER BAAN Bastiaan van der Baan President and Chief Executive Officer 3 INDEX TO EXHIBITS Exhibit No. Description 99.1 Press release announcing the publication of pre-clinical data on the effect of Lixte's lead compound, LB-100, on cancer cells 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 4